Insmed Incorporated

NASDAQ (USD): Insmed Incorporated (INSM)

Last Price

68.03

Today's Change

+0.81 (1.20%)

Day's Change

66.67 - 68.19

Trading Volume

706,024

Overview

Market Cap

12 Billion

Shares Outstanding

182 Million

Avg Volume

2,256,601

Avg Price (50 Days)

72.04

Avg Price (200 Days)

73.40

PE Ratio

-11.49

EPS

-5.93

Earnings Announcement

06-Aug-2025

Previous Close

67.22

Open

67.47

Day's Range

66.63 - 68.29

Year Range

21.92 - 84.91

Trading Volume

1,740,758

Price Change Highlight

1 Day Change

1.34%

5 Day Change

4.51%

1 Month Change

-2.00%

3 Month Change

-16.27%

6 Month Change

2.27%

Ytd Change

-2.62%

1 Year Change

166.72%

3 Year Change

242.31%

5 Year Change

165.58%

10 Year Change

190.99%

Max Change

-58.72%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. Insmed Incorporated was founded in 1988 and is headquartered in Bridgewater, New Jersey.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment